ACAD
41.69
+0.02
+0.05%
AEMD
6.9
-0.1
-1.43%
APRI
1.85
+0.17
+10.12%
ARNA
4.44
-0.03
-0.67%
ATEC
1.39
+0.01
+0.72%
CNAT
5.16
-0.08
-1.53%
CRXM
0.327
-0.033
-9.2778%
CYTX
0.548
-0.003
-0.5449%
DXCM
79.36
-0.41
-0.51%
GNMK
8.91
+0.16
+1.83%
HALO
22.1
-0.4
-1.78%
ILMN
220.07
-0.61
-0.28%
INNV
0.12
0.00
0.00%
INO
7.92
-0.22
-2.70%
ISCO
0.043
-0.003
-7.527%
ISIS
56.13
-1.03
-1.80%
LGND
98.6
+1.51
+1.56%
LPTN
0.275
-0.005
-1.6446%
MBVX
2.69
+0.17
+6.75%
MEIP
1.77
+0.07
+4.12%
MNOV
4.02
+0.09
+2.29%
MRTX
31.3
-0.39
-1.23%
MSTX
0.48
-0.01
-2.04%
NBIX
47.31
-0.35
-0.73%
NUVA
47.29
-0.23
-0.48%
ONCS
6.35
-0.25
-3.79%
ONVO
3.74
+0.03
+0.81%
OREX
4.76
-0.17
-3.45%
OTIC
22.09
-0.52
-2.30%
QDEL
23.01
+0.04
+0.17%
RCPT
194.91
-1.36
-0.69%
RGLS
10.2
-0.34
-3.23%
RMD
55.31
+0.01
+0.02%
SCIE
0.016
0.00
0.00%
SPHS
0.823
+0.04
+5.149%
SRNE
16.68
-0.53
-3.08%
TROV
9.53
-0.19
-1.95%
VICL
0.7
+0.015
+2.1752%
ZGNX
12.8
-1.16
-8.31%
ACAD
41.69
+0.02
+0.05%
AEMD
6.9
-0.1
-1.43%
APRI
1.85
+0.17
+10.12%
ARNA
4.44
-0.03
-0.67%
ATEC
1.39
+0.01
+0.72%
CNAT
5.16
-0.08
-1.53%
CRXM
0.327
-0.033
-9.2778%
CYTX
0.548
-0.003
-0.5449%
DXCM
79.36
-0.41
-0.51%
GNMK
8.91
+0.16
+1.83%
HALO
22.1
-0.4
-1.78%
ILMN
220.07
-0.61
-0.28%
INNV
0.12
0.00
0.00%
INO
7.92
-0.22
-2.70%
ISCO
0.043
-0.003
-7.527%
ISIS
56.13
-1.03
-1.80%
LGND
98.6
+1.51
+1.56%
LPTN
0.275
-0.005
-1.6446%
MBVX
2.69
+0.17
+6.75%
MEIP
1.77
+0.07
+4.12%
MNOV
4.02
+0.09
+2.29%
MRTX
31.3
-0.39
-1.23%
MSTX
0.48
-0.01
-2.04%
NBIX
47.31
-0.35
-0.73%
NUVA
47.29
-0.23
-0.48%
ONCS
6.35
-0.25
-3.79%
ONVO
3.74
+0.03
+0.81%
OREX
4.76
-0.17
-3.45%
OTIC
22.09
-0.52
-2.30%
QDEL
23.01
+0.04
+0.17%
RCPT
194.91
-1.36
-0.69%
RGLS
10.2
-0.34
-3.23%
RMD
55.31
+0.01
+0.02%
SCIE
0.016
0.00
0.00%
SPHS
0.823
+0.04
+5.149%
SRNE
16.68
-0.53
-3.08%
TROV
9.53
-0.19
-1.95%
VICL
0.7
+0.015
+2.1752%
ZGNX
12.8
-1.16
-8.31%
Home » Archive by Category

Xconomy

Genentech Redux? Roche Buys Majority Stake in Foundation Medicine

January 11, 2015 – 11:00 pm

In a deal that shakes up the full-steam-ahead world of cancer diagnostics, the world’s top oncology drug company, Roche, said today it’s spending more than $1 billion for a majority stake in…

[[Click headline to continue reading.]]

Genentech Redux? Roche Buys Majority Stake in Foundation Medicine

January 11, 2015 – 11:00 pm

In a deal that shakes up the full-steam-ahead world of cancer diagnostics, the world’s top oncology drug company, Roche, said today it’s spending more than $1 billion for a majority stake in…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More

January 8, 2015 – 1:44 pm

What a week for life sciences news, and it’s not even over. Perhaps we’ll get a slight break as the healthcare and biopharma worlds get on airplanes and descend upon San Francisco…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More

January 8, 2015 – 1:44 pm

What a week for life sciences news, and it’s not even over. Perhaps we’ll get a slight break as the healthcare and biopharma worlds get on airplanes and descend upon San Francisco…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More

January 8, 2015 – 1:44 pm

What a week for life sciences news, and it’s not even over. Perhaps we’ll get a slight break as the healthcare and biopharma worlds get on airplanes and descend upon San Francisco…

[[Click headline to continue reading.]]

GlySens Raises $12M for Wireless Implantable Glucose Sensor

January 7, 2015 – 5:33 pm

San Diego-based GlySens says it has raised $12 million in Series C funding to advance its wireless technology for an implantable sensor that could be used to monitor blood sugar levels in people with…

[[Click headline to continue reading.]]

GlySens Raises $12M for Wireless Implantable Glucose Sensor

January 7, 2015 – 5:33 pm

San Diego-based GlySens says it has raised $12 million in Series C funding to advance its wireless technology for an implantable sensor that could be used to monitor blood sugar levels in people with…

[[Click headline to continue reading.]]

Even When Money is Easy, Rules of Biotech Finance Still Apply

January 7, 2015 – 12:40 am

Last month Juno Therapeutics closed a $250 million IPO, bringing the total raised since it was founded in Seattle in 2013 to close to $600 million. The money is earmarked to support more than ten…

[[Click headline to continue reading.]]

Even When Money is Easy, Rules of Biotech Finance Still Apply

January 7, 2015 – 12:40 am

Last month Juno Therapeutics closed a $250 million IPO, bringing the total raised since it was founded in Seattle in 2013 to close to $600 million. The money is earmarked to support more than ten…

[[Click headline to continue reading.]]

Tracon Files for $57.5M IPO to Move Cancer Drugs to Next Stage

January 6, 2015 – 12:40 am

San Diego-based Tracon Pharmaceuticals, which raised $27 million in a Series B financing round in September, plans to raise a total of $57.5 million in an IPO, according to a recent regulatory…

[[Click headline to continue reading.]]